» Articles » PMID: 30854252

Chronic Fatigue Syndrome Prevalence is Grossly Overestimated Using Oxford Criteria Compared to Centers for Disease Control (Fukuda) Criteria in a U.S. Population Study

Overview
Journal Fatigue
Date 2019 Mar 12
PMID 30854252
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Results from treatment studies using the low threshold Oxford criteria for recruitment may have been overgeneralized to patients diagnosed by more stringent CFS criteria.

Purpose: To compare the selectivity of Oxford and Fukuda criteria in a U.S. population.

Methods: Fukuda (Center for Disease Control (CDC)) criteria, as operationalized with the CFS Severity Questionnaire (CFSQ), were included in the nationwide rc2004 HealthStyles survey mailed to 6,175 participants who were representative of the US 2003 Census population. The 9 questionnaire items (CFS symptoms) were crafted into proxies for Oxford criteria (mild fatigue, minimal exclusions) and Fukuda criteria (fatigue plus ≥4 of 8 ancillary criteria at moderate or severe levels with exclusions). The comparative prevalence estimates of CFS were then determined. Severity scores for fatigue were plotted against the sum of severities for the 8 ancillary criteria. The 4 quadrants of scatter diagrams assessed putative healthy controls, CFS, chronic idiopathic fatigue, and CFS-like with insufficient fatigue subjects.

Results: The Oxford criteria designated CFS in 25.5% of 2,004 males and 19.9% of 1,954 females. Based on quadrant analysis, 85% of Oxford-defined cases were inappropriately classified as CFS. Fukuda criteria identified CFS in 2.3% of males and 1.8% of females.

Discussion: CFS prevalence using Fukuda criteria and quadrant analysis were near the upper limits of previous epidemiology studies. The CFSQ may have utility for on-line and outpatient screening. The Oxford criteria were untenable because they inappropriately selected healthy subjects with mild fatigue and chronic idiopathic fatigue and mislabeled them as CFS.

Citing Articles

The Effects of Peanut Oligopeptides on Exercise-Induced Fatigue in Mice and Its Underlying Mechanism.

Liu R, Li Z, Yu X, Hu J, Zhu N, Liu X Nutrients. 2023; 15(7).

PMID: 37049582 PMC: 10096783. DOI: 10.3390/nu15071743.


[Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence].

Ludwig B, Olbert E, Trimmel K, Seidel S, Rommer P, Muller C Nervenarzt. 2023; 94(8):725-733.

PMID: 36695893 PMC: 9875188. DOI: 10.1007/s00115-022-01431-x.


The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.

Vink M, Vink-Niese A Healthcare (Basel). 2022; 10(5).

PMID: 35628033 PMC: 9141828. DOI: 10.3390/healthcare10050898.


Review of the Midbrain Ascending Arousal Network Nuclei and Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Gulf War Illness (GWI) and Postexertional Malaise (PEM).

Baraniuk J Brain Sci. 2022; 12(2).

PMID: 35203896 PMC: 8870178. DOI: 10.3390/brainsci12020132.


Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

Sharpe M, Chalder T, White P J Gen Intern Med. 2021; 37(2):449-452.

PMID: 34791590 PMC: 8811058. DOI: 10.1007/s11606-021-07188-4.


References
1.
Wagner D, Nisenbaum R, Heim C, Jones J, Unger E, Reeves W . Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr. 2005; 3:8. PMC: 1183246. DOI: 10.1186/1478-7954-3-8. View

2.
Vincent A, Brimmer D, Whipple M, Jones J, Boneva R, Lahr B . Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project. Mayo Clin Proc. 2012; 87(12):1145-52. PMC: 3518652. DOI: 10.1016/j.mayocp.2012.08.015. View

3.
Bates D, Buchwald D, Lee J, Kith P, Doolittle T, Umali P . A comparison of case definitions of chronic fatigue syndrome. Clin Infect Dis. 1994; 18 Suppl 1:S11-5. DOI: 10.1093/clinids/18.supplement_1.s11. View

4.
Baraniuk J, Adewuyi O, Merck S, Ali M, Ravindran M, Timbol C . A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria. Am J Transl Res. 2013; 5(1):53-68. PMC: 3560481. View

5.
White P, Goldsmith K, Johnson A, Potts L, Walwyn R, DeCesare J . Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011; 377(9768):823-36. PMC: 3065633. DOI: 10.1016/S0140-6736(11)60096-2. View